These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

976 related articles for article (PubMed ID: 21668312)

  • 1. Subcutaneous versus sublingual immunotherapy for allergic rhinitis and/or asthma.
    Bahceciler NN; Cobanoglu N
    Immunotherapy; 2011 Jun; 3(6):747-56. PubMed ID: 21668312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The value and possibilities of immunotherapy in the treatment of allergic rhinitis].
    Pfaar O; Hörmann K; Klimek L
    MMW Fortschr Med; 2006 Feb; 148(5):28-32. PubMed ID: 16518935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One century of allergen-specific immunotherapy for respiratory allergy.
    Incorvaia C; Frati F
    Immunotherapy; 2011 May; 3(5):629-35. PubMed ID: 21554092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subcutaneous immunotherapy versus sublingual immunotherapy: which is more effective?
    Nelson HS
    J Allergy Clin Immunol Pract; 2014; 2(2):144-9; quiz 150-1. PubMed ID: 24607040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sublingual immunotherapy.
    Lin SY; Leatherman B
    Otolaryngol Clin North Am; 2011 Jun; 44(3):753-64, x-xi. PubMed ID: 21621059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allergen-specific immunotherapy in allergic rhinitis and asthma. Mechanisms and proof of efficacy.
    Pipet A; Botturi K; Pinot D; Vervloet D; Magnan A
    Respir Med; 2009 Jun; 103(6):800-12. PubMed ID: 19216064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Vaccination with allergens in children].
    Demoly P; Dhivert-Donnadieu H; Bousquet J
    Allerg Immunol (Paris); 2000 Dec; 32(10):397-401. PubMed ID: 11209473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiallergen immunotherapy for allergic rhinitis and asthma.
    Nelson HS
    J Allergy Clin Immunol; 2009 Apr; 123(4):763-9. PubMed ID: 19217653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meta-analyses of specific immunotherapy trials.
    Calderon MA
    Drugs Today (Barc); 2008 Dec; 44 Suppl B():31-4. PubMed ID: 19221615
    [No Abstract]   [Full Text] [Related]  

  • 10. A pilot study of feasibility of ultra-rush (20-25 minutes) sublingual-swallow immunotherapy in 679 patients (699 sessions) with allergic rhinitis and/or asthma.
    Rossi RE; Monasterolo G
    Int J Immunopathol Pharmacol; 2005; 18(2):277-85. PubMed ID: 15888250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changing the route of immunotherapy administration: an 18-year survey in pediatric patients with allergic rhinitis and asthma.
    Pajno GB; Caminiti L; Passalacqua G
    Allergy Asthma Proc; 2013; 34(6):523-6. PubMed ID: 24169060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of sublingual specific immunotherapy on allergic asthma and rhinitis in children's real life.
    De Castro G; Zicari AM; Indinnimeo L; Tancredi G; di Coste A; Occasi F; Castagna G; Giancane G; Duse M
    Eur Rev Med Pharmacol Sci; 2013 Aug; 17(16):2225-31. PubMed ID: 23893190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sublingual immunotherapy is not always a safe alternative to subcutaneous immunotherapy.
    Cochard MM; Eigenmann PA
    J Allergy Clin Immunol; 2009 Aug; 124(2):378-9. PubMed ID: 19541352
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy of subcutaneous and sublingual immunotherapy with grass allergens for seasonal allergic rhinitis: a meta-analysis-based comparison.
    Di Bona D; Plaia A; Leto-Barone MS; La Piana S; Di Lorenzo G
    J Allergy Clin Immunol; 2012 Nov; 130(5):1097-1107.e2. PubMed ID: 23021885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of sublingual immunotherapy.
    Scadding G; Durham S
    J Asthma; 2009 May; 46(4):322-34. PubMed ID: 19484663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sublingual or subcutaneous immunotherapy for allergic rhinitis?
    Durham SR; Penagos M
    J Allergy Clin Immunol; 2016 Feb; 137(2):339-349.e10. PubMed ID: 26853126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of one-year subcutaneous and sublingual immunotherapy on clinical and laboratory parameters in children with rhinitis and asthma: a randomized, placebo-controlled, double-blind, double-dummy study.
    Yukselen A; Kendirli SG; Yilmaz M; Altintas DU; Karakoc GB
    Int Arch Allergy Immunol; 2012; 157(3):288-98. PubMed ID: 22041501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Real-life compliance and persistence among users of subcutaneous and sublingual allergen immunotherapy.
    Kiel MA; Röder E; Gerth van Wijk R; Al MJ; Hop WC; Rutten-van Mölken MP
    J Allergy Clin Immunol; 2013 Aug; 132(2):353-60.e2. PubMed ID: 23651609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific allergy immunotherapy for allergic rhinitis: subcutaneous and sublingual.
    Cox L; Wallace D
    Immunol Allergy Clin North Am; 2011 Aug; 31(3):561-99. PubMed ID: 21737043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subcutaneous and sublingual immunotherapy for allergic rhinitis: what is the evidence?
    Wise SK; Schlosser RJ
    Am J Rhinol Allergy; 2012; 26(1):18-22. PubMed ID: 22391071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.